Výsledky vyhledávání - Allison P. Jacob

  • Zobrazuji výsledky 1 - 9 z 9
Upřesnit hledání
  1. 1
    RANK and RANK ligand expression in primary human osteosarcoma

    RANK and RANK ligand expression in primary human osteosarcoma Autor Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

    Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma Autor Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg, Esther Mena, Ethan Bergvall, Andrea N. Lucas, Allison P. Jacob, Erik Yusko, Seth M. Steinberg, Elaine S. Jaffe, Adrian Wiestner, Wyndham H. Wilson, Mark Roschewski

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

    SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm Autor Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel, Mark Tometsko, Brooke M. Rock, Sonal Patel, Robert R. Milburn, Sophia Siu, Seamus P. Ragan, Dan A. Rock, Christopher J. Borths, Jason O’Neill, Wesley Chang, Margaret F. Weidner, Matthew M. Bio, Kim Quon, William C. Fanslow

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

    Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional T... Autor Matthew J. Frank, Nasheed Hossain, Ali Bukhari, Erin Dean, Jay Y. Spiegel, Gursharan K. Claire, Ilan Kirsch, Allison P. Jacob, Chelsea Mullins, Lik Wee Lee, Katherine A. Kong, Juliana Craig, Crystal L. Mackall, Aaron P. Rapoport, Michael D. Jain, Saurabh Dahiya, Frederick L. Locke, David B. Miklos

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

    CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma Autor John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren Younes, Michael G. Ozawa, Eric Yang, Yasodha Natkunam, John Tamaresis, Zachary Ehlinger, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen‐Kai Weng, Kara L. Davis, Sneha Ramakrishna, Liora M. Schultz, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

    Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma Autor Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright, Jillian Simard, Jagan Muppidi, Craig J. Thomas, Michele Ceribelli, Frances A. Tosto, Yandan Yang, Weihong Xu, Theresa Davies‐Hill, Svetlana Pack, Cody J. Peer, Oluwatobi Arisa, Esther Mena, Liza Lindenberg, Ethan Bergvall, Craig A. Portell, Rafic Farah, Seung‐Tae Lee, Amynah Pradhan, Candis Morrison, Atekelt Tadese, Anna Marie Juanitez, Crystal Lu, Allison P. Jacob, Heidi Simmons, William D. Figg, Seth M. Steinberg, Elaine S. Jaffe, Mark Roschewski, Louis M. Staudt, Wyndham H. Wilson

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

    Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphoc... Autor Jacob D. Soumerai, Anthony R. Mato, Ahmet Doǧan, Venkatraman Seshan, Erel Joffe, K. T. Flaherty, Jason Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Audrey M. Hamilton, Jeremy S. Abramson, Connie Lee Batlevi, Matthew J. Matasar, Ariela Noy, Colette Owens, M. Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma, Chaya Friedman, Puja Chadha, Elizabeth Simkins, Jade Ruiters, Sidney Sechio, Daneal Portman, Lauren Ramos, Natascha Nolet, Neena Mahajan, Rosalba Martignetti, Joanna Mi, Krista J. Scorsune, Julia Lynch, Brianne McGree, Stephanie Hughes, Clare Grieve, Lindsey E. Roeker, Meghan C. Thompson, P. Connor Johnson, Mikhail Roshal, Jane Huang, Juliana Biondo, Qun Wu, Allison P. Jacob, Omar Abdel‐Wahab, Andrew D. Zelenetz

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL

    LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL Autor Jacob D. Soumerai, Ahmet Doǧan, Venkatraman Seshan, K. T. Flaherty, J. Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Amber Hamilton, Ariela Noy, C. N. Owens, M. Lia Palomba, Anita Kumar, Lindsey E. Roeker, Meghan C. Thompson, Ronald W. Takvorian, Zachary D. Epstein‐Peterson, Mark B. Geyer, W. Ramos‐Amador, Neena Mahajan, Rosalba Martignetti, Sue Plummer, Jia Mi, J. M. Lynch, Brianne McGree, M. M. Sherburne, E. N. Patterson, Natalie Slupe, Maria Chabowska, A. Labarre, Theodore J. Choma, G. McCambridge, Hillary R. Kelly, Margaret Devlin, Madeline Puccio, R. García, Clare Grieve, A. Cohen, Juliana Biondo, Allison P. Jacob, Omar Abdel‐Wahab, Andrew D. Zelenetz

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

    CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial Autor Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird, Matthew J. Frank, Parveen Shiraz, Bita Sahaf, Juliana Craig, María Iglesias, Sheren Younes, Yasodha Natkunam, Michael G. Ozawa, Eric Yang, John Tamaresis, Harshini Chinnasamy, Zachary Ehlinger, Warren D. Reynolds, Rachel C. Lynn, Maria Caterina Rotiroti, Nikolaos Gkitsas, Sally Arai, Laura Johnston, Robert Lowsky, Robbie G. Majzner, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Judith A. Shizuru, Wen‐Kai Weng, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Magali Bazzano, Jing Zhou, Sean Mackay, Scott J. Bornheimer, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Katherine A. Kong, Nirali N. Shah, Haiying Qin, Terry J. Fry, Steven A. Feldman, Crystal L. Mackall, David B. Miklos

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: